Clobetasol propionate, a Nrf-2 inhibitor, sensitizes human lung cancer cells to radiation-induced killing via mitochondrial ROS-dependent ferroptosis

• Published in: Acta pharmacologica Sinica 2024-07, Vol.45 (7), p.1506-1519
• Main Authors: Rai, Archita, Patwardhan, Raghavendra S., Jayakumar, Sundarraj, Pachpatil, Pradnya, Das, Dhruv, Panigrahi, Girish Ch, Gota, Vikram, Patwardhan, Sejal, Sandur, Santosh K.
• Format: Article
• Language: English
• Subjects: A549 Cells; Biomedical and Life Sciences; Biomedicine; Clobetasol - pharmacology; Ferroptosis - drug effects; Humans; Immunology; Internal Medicine; Lipid Peroxidation - drug effects; Lung Neoplasms - drug therapy; Lung Neoplasms - metabolism; Lung Neoplasms - pathology; Medical Microbiology; Mitochondria - drug effects; Mitochondria - metabolism; Mitochondria - radiation effects; NF-E2-Related Factor 2 - antagonists & inhibitors; NF-E2-Related Factor 2 - metabolism; Oxidative Stress - drug effects; Pharmacology/Toxicology; Radiation-Sensitizing Agents - pharmacology; Reactive Oxygen Species - metabolism; Vaccine
• ISSN: 1671-4083; 1745-7254; 1745-7254
• DOI: 10.1038/s41401-024-01233-8

Combining radiotherapy with Nrf-2 inhibitor holds promise as a potential therapeutic strategy for radioresistant lung cancer. Here, the radiosensitizing efficacy of a synthetic glucocorticoid clobetasol propionate (CP) in A549 human lung cancer cells was evaluated. CP exhibited potent radiosensitization in lung cancer cells via inhibition of Nrf-2 pathway, leading to elevation of oxidative stress. Transcriptomic studies revealed significant modulation of pathways related to ferroptosis, fatty acid and glutathione metabolism. Consistent with these findings, CP treatment followed by radiation exposure showed characteristic features of ferroptosis in terms of mitochondrial swelling, rupture and loss of cristae. Ferroptosis is a form of regulated cell death triggered by iron-dependent ROS accumulation and lipid peroxidation. In combination with radiation, CP showed enhanced iron release, mitochondrial ROS, and lipid peroxidation, indicating ferroptosis induction. Further, iron chelation, inhibition of lipid peroxidation or scavenging mitochondrial ROS prevented CP-mediated radiosensitization. Nrf-2 negatively regulates ferroptosis through upregulation of antioxidant defense and iron homeostasis. Interestingly, Nrf-2 overexpressing A549 cells were refractory to CP-mediated ferroptosis induction and radiosensitization. Thus, this study identified anti-psoriatic drug clobetasol propionate can be repurposed as a promising radiosensitizer for Keap-1 mutant lung cancers.